Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2023 |
| Restructuring Cost and Reserve [Line Items] |
|
| Schedule of Deferred Tax Assets and Liabilities |
The
Components of the deferred tax assets and liabilities at December 31, 2023 and 2022 were approximately as follows:
Schedule
of Deferred Tax Assets and Liabilities
| | |
December
31,
2023 | | |
December
31,
2022 | |
| Deferred
Tax Assets | |
| | | |
| | |
| Stock
based compensation | |
$ | 142,000 | | |
$ | 203,000 | |
| Intangibles | |
| 719,000 | | |
| 908,000 | |
| Net
operating loss carryforward | |
| 10,775,000 | | |
| 8,147,000 | |
| Lease
liabilities | |
| 80,000 | | |
| 138,000 | |
| Capitalized
research expenditures | |
| 367,000 | | |
| 354,000 | |
| Bad
debt reserve | |
| 21,000 | | |
| - | |
| Other | |
| 9,000 | | |
| 8,000 | |
| Total
deferred tax assets | |
| 12,113,000 | | |
| 9,758,000 | |
| | |
| | | |
| | |
| Deferred
Tax Liabilities | |
| | | |
| | |
| Depreciation | |
| (683,000 | ) | |
| (872,000 | ) |
| Prepaid
assets | |
| (47,000 | ) | |
| (34,000 | ) |
| Right-of-Use
asset | |
| (75,000 | ) | |
| (132,000 | ) |
| Total
deferred tax liabilities | |
| (805,000 | ) | |
| (1,038,000 | ) |
| | |
| | | |
| | |
| Deferred
Tax Assets | |
| 11,308,000 | | |
| 8,720,000 | |
| Less:
valuation allowance | |
| (11,308,000 | ) | |
| (8,720,000 | ) |
| Deferred
tax asset – net | |
$ | - | | |
$ | - | |
|
| Schedule of Income Tax Benefit and Related Valuation Allowance |
The
components of the income tax benefit and related valuation allowance for the years ended December 31, 2023 and 2022 was approximately
as follows:
Schedule
of Income Tax Benefit and Related Valuation Allowance
| | |
December
31,
2023 | | |
December
31,
2022 | |
| Current | |
$ | - | | |
$ | - | |
| Deferred | |
| (2,588,000 | ) | |
| (4,149,000 | ) |
| Total
income tax provision (benefit) | |
| (2,588,000 | ) | |
| (4,149,000 | ) |
| Less:
valuation allowance | |
| 2,588,000 | | |
| 4,149,000 | |
| Total Tax Provision | |
$ | - | | |
$ | - | |
|
| Schedule of Reconciliation of Provision for Income Taxes |
A
reconciliation of the provision for income taxes for the years ended December 31, 2023 and 2022 as compared to statutory rates was approximately
as follows:
Schedule
of Reconciliation of Provision for Income Taxes
| | |
December
31,
2023 | | |
December
31,
2022 | |
| Federal
income tax expense (benefit) - 21% | |
$ | (2,199,000 | ) | |
$ | (3,676,000 | ) |
| State
income tax expense (benefit) - 4.35% - net of federal effect | |
| (455,000 | ) | |
| (761,000 | ) |
| Permanent
differences – net | |
| (25,000 | ) | |
| 255,000 | |
| Deferred
adjustments | |
| 91,000 | | |
| 33,000 | |
| Change
in valuation allowance | |
| 2,588,000 | | |
| 4,149,000 | |
| Income
tax expense (benefit) | |
$ | - | | |
$ | - | |
|
| Schedule of Operating Loss Carry Forwards |
Federal
net operating loss carry forwards at December 31, 2023 and 2022 were approximately as follows:
Schedule
of Operating Loss Carry Forwards
| December
31, 2023 | | |
December
31, 2022 | |
| | | |
| |
| $ | 43,000,000 | | |
$ | 33,000,000 | |
|
| Next NRG Holding Corp [Member] |
|
| Restructuring Cost and Reserve [Line Items] |
|
| Schedule of Deferred Tax Assets and Liabilities |
The tax effects of temporary differences that
give rise to significant portions of deferred tax assets and liabilities at December 31, 2023 and 2022 are approximately as
follows:
Schedule
of Deferred Tax Assets and Liabilities
| | |
December
31, 2023 | | |
December
31, 2022 | |
| Deferred
Tax Assets | |
| | | |
| | |
| Net
operating loss carryforwards | |
| (112,000 | ) | |
| (3,000 | ) |
| Total
deferred tax assets | |
| (112,000 | ) | |
| (3,000 | ) |
| Less:
valuation allowance | |
| 112,000 | | |
| 3,000 | |
| Net
deferred tax asset recorded | |
$ | - | | |
$ | - | |
|
| Schedule of Reconciliation of Provision for Income Taxes |
The Company’s tax expense differs from the “expected”
tax expense for the period are approximately as follows:
Schedule
of Reconciliation of Provision for Income Taxes
| | |
December
31, 2023 | | |
December
31, 2022 | |
| Federal
income tax benefit - 21% | |
$ | (125,000 | ) | |
$ | (3,000 | ) |
| Non-deductible
items | |
| 16,000 | | |
| - | |
| Subtotal | |
| (109,000 | ) | |
| (3,000 | ) |
| Change
in valuation allowance | |
| 109,000 | | |
| 3,000 | |
| Income
tax benefit | |
$ | - | | |
$ | - | |
|